“…Shih C-C et al 23) 2012 33) In 1997∼2010, 9.25% patients with newly diagnosed acute myeloid leukemia and received radiotherapy and chemotherapy used TEAM 34) Colon cancer In 2004∼2008, 19.81% of newly diagnosed colon cancer patients used TEAM 35) In 2007, 26.9% of newly diagnosed colorectal cancer patients used TEAM 36) Head and neck cancer In 2000∼2011, 37.51% of newly diagnosed head and neck cancer patients used TEAM 37) Pediatric cancer In 2001∼2011, 62.37% of newly diagnosed pediatric cancer patients used TEAM 38) Breast cancer In 1999∼2008, 81.55% of newly diagnosed breast cancer patients used TEAM 39) In 2007, 35.6% of breast cancer patients used TEAM 40) In 2009, 37.33% of breast cancer patients used TEAM 41) Uterine fibroid In 2000∼2003, 73.33% of newly diagnosed uterine fibroid patients used TEAM 42) In 1996∼2010, 25.84% of uterine fibroid patients used TEAM 43) In 2002∼2010, 87.08% of newly diagnosed uterine fibroid patients used TEAM 44) Prostate cancer In 1996∼2008, 38.8% of prostate cancer patients used TEAM 45) In 1998∼2003, 64.5% of newly diagnosed prostate cancer patients used TEAM 46) In 2003∼2008, 52.6% of prostate cancer patients used TEAM 47) In 2007, 22.4% of outpatients with prostate cancer received prescription of herbal medicine 48) Lung cancer In 1996∼2010, Of the lung cancer patients, 31.17% of the operation patients and 26.32% of the non-operation patients used TEAM 49) Endocrine, nutritional and metabolic diseases, and immunity disorders (3.59%) Hyperlipidemia In 2003∼2009, 82.95% of hyperlipidemia patients used TEAM 50) Diabetes mellitus In 2000∼2011, 20.55% of type I diabetes mellitus patients used TEAM 51) In 1998∼2008, 77.91% of newly diagnosed type II diabetes mellitus adult patients used TEAM 52) Mental disorders (3.10%)…”